Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in <i>JAK2</i>-mutated myeloproliferative neoplasms.

Haematologica · 2017 · PMC5394969 · PMID 28057739

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

of borderline significanceP =0.051so close (0.05 < p ≤ 0.1)

Patients whose granulocytes harbored increased HMGA2 expression had a higher probability of carrying a driver mutation than those without, though the comparison was of borderline significance (93.1% vs . 77.0%, P =0.051).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.